Guardant360® CDx Liquid Biopsy CE-Marked for Comprehensive Tumor Mutation Profiling Across All Solid Cancers
Singlera Genomics raises $150 million in Series B financing to promote the development and commercialization of early cancer screening products
Leading Diagnostics Companies Join Forces to Establish the Access to Comprehensive Genomic Profiling Coalition (ACGP)
Biofidelity raises $12m in Series A financing to accelerate launch of disruptive cancer diagnostic technology